1. Home
  2. SID vs FDMT Comparison

SID vs FDMT Comparison

Compare SID & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia Siderurgica Nacional S.A.

SID

Companhia Siderurgica Nacional S.A.

N/A

Current Price

$0.51

Market Cap

833.8M

Sector

Industrials

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$10.14

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SID
FDMT
Founded
1941
2013
Country
Brazil
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
833.8M
695.3M
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
SID
FDMT
Price
$0.51
$10.14
Analyst Decision
Sell
Strong Buy
Analyst Count
4
12
Target Price
$1.17
★ $28.09
AVG Volume (30 Days)
★ 10.8M
855.5K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.79
EPS
★ N/A
N/A
Revenue
N/A
★ $85,209,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.87
$20.79
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 230194.60
52 Week Low
$0.55
$6.96
52 Week High
$2.20
$16.93

Technical Indicators

Market Signals
Indicator
SID
FDMT
Relative Strength Index (RSI) 24.87 37.51
Support Level N/A $8.43
Resistance Level $1.34 $10.61
Average True Range (ATR) 0.07 0.85
MACD -0.02 -0.15
Stochastic Oscillator 1.23 1.07

Price Performance

Historical Comparison
SID
FDMT

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations port concessions and fleets of road transport vehicles. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: